Total Payments
$2,059
2024 Payments
$1,224
Companies
8
Transactions
32
Medicare Patients
1,142
Medicare Billing
$158,208
Payment Breakdown by Category
Consulting$840.00 (40.8%)
Food & Beverage$678.92 (33.0%)
Other$540.00 (26.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $840.00 | 1 | 40.8% |
| Food and Beverage | $678.92 | 17 | 33.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $540.00 | 14 | 26.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $990.00 | 2 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $540.00 | 14 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $165.31 | 4 | $0 (2023) |
| ABBVIE INC. | $142.43 | 6 | $0 (2024) |
| GENZYME CORPORATION | $132.05 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $45.41 | 3 | $0 (2024) |
| Celgene Corporation | $24.95 | 1 | $0 (2017) |
| Horizon Pharma plc | $18.77 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,224 | 8 | Janssen Scientific Affairs, LLC ($990.00) |
| 2023 | $126.37 | 3 | Novartis Pharmaceuticals Corporation ($95.48) |
| 2022 | $23.40 | 1 | Novartis Pharmaceuticals Corporation ($23.40) |
| 2017 | $685.00 | 20 | SANOFI-AVENTIS U.S. LLC ($540.00) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/11/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $132.05 | General |
| Category: Rheumatology | ||||||
| 08/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: IMMUNOLOGY | ||||||
| 07/27/2024 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $840.00 | General |
| Category: Immunology | ||||||
| 07/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: IMMUNOLOGY | ||||||
| 07/11/2024 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Immunology | ||||||
| 06/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: IMMUNOLOGY | ||||||
| 05/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: IMMUNOLOGY | ||||||
| 01/24/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: IMMUNOLOGY | ||||||
| 10/20/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $95.48 | General |
| Category: Dermatology | ||||||
| 09/14/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: IMMUNOLOGY | ||||||
| 05/04/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2017 | SANOFI-AVENTIS U.S. LLC | SYNVISC-ONE (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $40.00 | General |
| Category: OSTEOARTHRITIS | ||||||
| 12/01/2017 | SANOFI-AVENTIS U.S. LLC | SYNVISC-ONE (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $40.00 | General |
| Category: OSTEOARTHRITIS | ||||||
| 11/01/2017 | SANOFI-AVENTIS U.S. LLC | SYNVISC-ONE (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $40.00 | General |
| Category: OSTEOARTHRITIS | ||||||
| 10/04/2017 | SANOFI-AVENTIS U.S. LLC | SYNVISC-ONE (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $40.00 | General |
| Category: OSTEOARTHRITIS | ||||||
| 10/04/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: Immunology | ||||||
| 09/06/2017 | SANOFI-AVENTIS U.S. LLC | SYNVISC-ONE (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $40.00 | General |
| Category: OSTEOARTHRITIS | ||||||
| 08/02/2017 | SANOFI-AVENTIS U.S. LLC | SYNVISC-ONE (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $40.00 | General |
| Category: OSTEOARTHRITIS | ||||||
| 07/05/2017 | SANOFI-AVENTIS U.S. LLC | SYNVISC-ONE (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $40.00 | General |
| Category: OSTEOARTHRITIS | ||||||
| 06/13/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $28.47 | General |
| Category: Immunology | ||||||
| 06/07/2017 | SANOFI-AVENTIS U.S. LLC | SYNVISC-ONE (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $40.00 | General |
| Category: OSTEOARTHRITIS | ||||||
| 05/23/2017 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Dermatology | ||||||
| 05/09/2017 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: DERMATOLOGY | ||||||
| 05/03/2017 | SANOFI-AVENTIS U.S. LLC | SYNVISC-ONE (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $40.00 | General |
| Category: OSTEOARTHRITIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 355 | 691 | $286,430 | $55,624 |
| 2022 | 4 | 274 | 525 | $206,070 | $39,385 |
| 2021 | 3 | 257 | 443 | $182,000 | $34,529 |
| 2020 | 3 | 256 | 462 | $184,023 | $28,670 |
Total Patients
1,142
Total Services
2,121
Medicare Billing
$158,208
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 269 | 578 | $231,200 | $44,788 | 19.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 57 | 57 | $42,750 | $8,061 | 18.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 17 | 44 | $5,280 | $1,758 | 33.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $7,200 | $1,016 | 14.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 215 | 446 | $178,400 | $33,209 | 18.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 34 | 34 | $20,400 | $3,819 | 18.7% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 13 | 17 | $3,910 | $1,444 | 36.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 12 | 28 | $3,360 | $913.35 | 27.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 192 | 362 | $144,800 | $28,332 | 19.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 41 | 57 | $22,800 | $3,560 | 15.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 24 | 24 | $14,400 | $2,637 | 18.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 177 | 353 | $141,200 | $20,326 | 14.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 52 | 82 | $26,623 | $5,475 | 20.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 27 | 27 | $16,200 | $2,869 | 17.7% |
About Dr. Stratos Christianakis, M.D
Dr. Stratos Christianakis, M.D is a Internal Medicine healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831114008.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stratos Christianakis, M.D has received a total of $2,059 in payments from pharmaceutical and medical device companies, with $1,224 received in 2024. These payments were reported across 32 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($840.00).
As a Medicare-enrolled provider, Christianakis has provided services to 1,142 Medicare beneficiaries, totaling 2,121 services with total Medicare billing of $158,208. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Rheumatology
- Location Pasadena, CA
- Active Since 07/12/2006
- Last Updated 11/27/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1831114008
Products in Payments
- TREMFYA (Drug) $990.00
- SYNVISC-ONE (Device) $540.00
- KEVZARA (Biological) $132.05
- COSENTYX (Drug) $95.48
- RINVOQ (Biological) $87.58
- COSENTYX (Biological) $69.83
- Humira (Biological) $54.85
- BENLYSTA (Biological) $45.41
- Otezla (Drug) $24.95
- KRYSTEXXA (Drug) $18.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pasadena
Dr. Yuan Yuan, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $523,801
Internal Medicine $523,801
Christopher Dagher, M.d, M.D
Internal Medicine — Payments: $103,615
Internal Medicine $103,615
Peter Haddad, M.d, M.D
Internal Medicine — Payments: $87,600
Internal Medicine $87,600
Dr. Andrew Williams, M.d, M.D
Internal Medicine — Payments: $85,273
Internal Medicine $85,273
Joseph Dellinger, Md, MD
Internal Medicine — Payments: $77,175
Internal Medicine $77,175
Dr. Helen Moon, M.d, M.D
Internal Medicine — Payments: $61,882
Internal Medicine $61,882